Mortensen Medical Research Network · PPRN-001-2025

Legalizing Proactive Health.

The national observational registry for peptide and regenerative therapy, under independent IRB oversight. Licensed clinicians join free, sign here in four minutes, and submit de-identified outcomes. Every record builds the evidence that keeps this medicine in the open.

Already a participating site? Submit visit data.

Why this exists

Regulators act on evidence. Build it.

The therapies are already in clinics. Clinicians across the country use peptides and regenerative treatments every day. Almost none of what they see is recorded in a form anyone can study.

Silence is the risk. Without real-world data on dose, source, outcome and safety, every decision about these therapies gets made without the people who use them.

The registry is the record. Validated instruments, lot-level traceability and adverse-event reporting, sealed in a ledger nobody can quietly edit. Evidence that holds up.

Three steps, all here

Read. Sign. Submit data.

Everything happens on this site. No account with any company, no purchase, no fee.

01

Read the site consent

Version 2.0. What the registry is, what your site agrees to, how participants are protected. Five minutes.

Read the consent
02

Apply and sign

Principal investigator, license, NPI and clinic. Type your name to sign. We verify licensure and issue your site code and access key within two business days.

Join the registry
03

Submit visit data

De-identified, keyed to your site code and a registry subject number. Every record is sealed into your site's tamper-evident ledger.

Submit visit data

Plain terms

What the registry is, and is not.

The registry is

  • Observational. It documents what treating clinicians already do.
  • Overseen by an independent IRB for data collection and participant protection.
  • Voluntary for every site and every participant, with withdrawal at any time.
  • Built for evidence: validated instruments, lot traceability, safety reporting.

The registry is not

  • Approval of any product, dose or protocol. Nothing here is "IRB approved."
  • FDA approval, clearance or endorsement, or protection from any legal claim.
  • A condition of buying anything, from anyone.
  • A reason to market to patients.

Data

What we collect, and what never leaves your clinic.

Collected, de-identified

  • Registry subject number, age band and sex
  • Molecule, source class, lot and certificate of analysis
  • Dose, route, cadence, anatomic site, co-administered agents
  • Pain (NRS-11), validated function scores, analgesic use, global change
  • Adverse events, seriousness, severity and outcome
  • Timing as study day from baseline and year, never calendar dates

Never collected

  • Names, initials or signatures of patients
  • Dates of birth or full calendar dates
  • Addresses, phone numbers or email addresses
  • Medical record numbers or insurance identifiers
  • Photographs or free-text notes containing identifiers
7 daysSerious adverse event reporting window
5 business daysAll other adverse events
14 daysVisit data submission window
7 yearsRegistry record retention

What we need

Four things per visit. Ninety seconds.

More patients in the dataset means more statistical power. Statistical power is what turns "my patients do well on this" into evidence that regulators, payers and courts have to reckon with. That is how proactive care gets legalized: efficacy and safety, counted.

1

The protocol

Molecule, dose, unit, route. One line per molecule; a stack is three lines. Molecule, not brand.

2

The visit

Baseline, 4–8 weeks, 16 weeks, 6 months, 12 months. Study day since baseline, never a calendar date.

3

The outcome

Pain at rest and with activity, 0–10. At follow-ups, global change 1–7.

4

Safety

Any adverse event since the last visit, No or Yes. If Yes: serious, severity, relatedness, outcome.

Plus a registry ID, age band and sex. Everything else is optional. Open the form or send a batch CSV.

FAQ

Every question we get asked.

1. What data do you need?

Four things per visit. Everything else is optional.

1. The protocol. What was given.

  • Molecule (BPC-157, TB-500, semaglutide, tirzepatide, CJC-1295, ipamorelin, NAD+, MOTS-c, and so on). Molecule, not brand.
  • Dose and unit (500 mcg, 2.5 mg, 100 IU).
  • Route (subcutaneous, IM, intra-articular, oral, nasal, topical).
  • One line per molecule. A stack is three lines.

2. The visit. When.

  • Baseline, 4–8 weeks, 16 weeks, 6 months, 12 months.
  • Study day (days since baseline; baseline is 0). Never a calendar date.

3. The outcome. Did it work.

  • Pain at rest and pain with activity, 0–10.
  • At follow-ups: global change, 1–7 (1 = no change or worse, 7 = a great deal better).

4. Safety. Did anything go wrong.

  • Adverse event since last visit: No or Yes.
  • If Yes: serious?, severity, related to the protocol?, outcome.

Plus a registry ID (PPRN001-<site>-0001), age band (50-59) and sex. That is the whole form.

2. What else can we send if we have it?

Send it; every extra field sharpens the signal. None of it is required.

  • Source class (503A, 503B, FDA-approved, research-use-only), lot number, COA on file.
  • Concentration after reconstitution, cadence (daily, 2x/week), anatomic site, procedure code.
  • Co-administered agents in the same injectate (steroids, anesthetics). Flag these; they confound results.
  • A validated function score: KOOS-JR, HOOS-JR, QuickDASH, VISA-A, ODI, NDI, PROMIS.
  • NSAID days per week, opioid MME per week, steroid injections in the prior 6 months.
  • Days to return to work or sport. Surgery avoided or deferred.
3. What must we never send?

Names, dates of birth, calendar dates, phone, email, address, MRN or chart numbers, photos. The form blocks them. The key linking a registry ID to a patient stays at the clinic. We never see it and never want it.

4. Why no dates?

A visit date plus a ZIP code plus an age re-identifies people. Study day (0, 42, 112, 180, 365) and year carry all the science with none of the exposure.

5. What does the patient sign?

The participant informed consent at joinirb.com/forms/, in your office, kept in your chart. One signature covers every visit. Patients can withdraw any time; you send one "withdrew" record.

6. What does the clinician sign?

Once: the investigator agreement (PDF) or the online application at joinirb.com/apply/, which signs the site consent electronically. Two minutes. License and NPI are verified.

7. Do I need my own IRB?

No. One protocol, one IRB (IRCM), one registry. Your clinic is listed as a site under it. This is how Regenative Labs runs 30+ clinics under the same IRB.

8. Do I need a BAA or a data use agreement?

Not for de-identified data, which is the only kind we take. Networks that submit on behalf of many clinics sign a data coordinating agreement with the registry.

9. How does the data get to you?
  • One clinic: the web form at joinirb.com/data/, about 90 seconds per visit.
  • A network: the batch CSV at joinirb.com/forms/, one row per visit per molecule, submitted by the network coordinator. API endpoint for direct feeds is being built by our CTO.
10. When is it due?

Visit data within 14 days. Serious adverse events within 7 calendar days. Other adverse events within 5 business days.

11. Can I fix a mistake?

Yes. Submit a correction record that references the original record number. Originals are never edited or deleted; the ledger is append-only and hash-chained. That is what makes it evidence.

12. Who owns the data?

The registry, sponsored by Mortensen Medical, a 501(c)(3). Participating sites can request aggregate reports and are named as contributors on publications drawn from their data.

13. What do I get out of it?

Your outcomes, measured against everyone else's. Published evidence with your name on it. A regulatory posture: you treat under an active IRB protocol with prospective safety reporting, which is the strongest position a peptide clinic can hold today.

14. What can I say publicly?

"We participate in the PPRN-001-2025 registry under an active IRB protocol." Never "IRB approved" about any product, and never use the registry to sell anything.

15. What does it cost?

Nothing. No fee, no purchase, no account with any company.

16. Who do I call?

Registry, roster, adverse events: contact@mortensenmedical.com. Participant rights: IRCM IRB, (786) 271-2157.

Forms and documents

Download, print, sign, file.

The participant consent and the investigator agreement are the only two pieces of paper a clinic ever touches. Networks use the roster, the batch template and the onboarding guide.

Support the registry

Legalizing proactive health is not free, cheap or easy.

Joining costs a clinic nothing, and it never will. Running the registry does: secure infrastructure, independent IRB oversight, safety review, analysis and publication. Mortensen Medical is a 501(c)(3) nonprofit and pays for all of it with gifts and book sales.

501(c)(3) · Tax-deductible

Give to Mortensen Medical

Secure checkout by Stripe. Mortensen Medical is a 501(c)(3) nonprofit; no goods or services are provided in exchange for a gift. Your Stripe receipt is your tax record.

The book

The Cockroach Diet

M. Scott Mortensen's field manual for proactive health: what to eat, what to take, what to measure, and how to stay alive long enough for the science to catch up. Every copy helps fund the research.

Get the book

The people

Who runs the registry.

Oversight of participant protection belongs to the IRCM Institutional Review Board, which is independent of the sponsor. No IRB member is on this team.

M. Scott Mortensen, MD, MPAS, PA-C

M. Scott Mortensen, MD, MPAS, PA-C

Founder · Principal investigator

Thirty years on the front line: teenage EMT, paramedic, flight medic on the Alaskan North Slope, fire captain, PA-C, then an MD earned cum laude at fifty. Summited Everest. Chief medical officer on a Guinness-record row across the Arctic Ocean. Founder of Mortensen Medical and author of The Cockroach Diet.

Elaine Marquez Mortensen, ND

Clinical lead · Hormone therapy

Medical director at Mortensen Medical and one of the country's authorities on rhythmic bioidentical hormone replacement for women. PRP and injection medicine, biofeedback, and the functional cases everyone else gave up on. She draws the labs herself.

Sunil Kurup, MD

Co-principal investigator

Physician with an active medical license in every state. National medical director for multiple nationwide gym chains.

Kaveh Newmen, Esq.

Regulatory and IP counsel

Newmen Law, P.C. One of the quiet authorities on peptide regulation, 503A and 503B compounding, and the structures that let this work happen in daylight. Represents companies across the U.S. peptide sector.

Charlie Gamkong

Chief technology officer

Advanced Reasoning Technology. Architect of the registry's data systems: de-identified capture, tamper-evident ledgers and the infrastructure that turns clinic visits into evidence.